Healthcare professionals frequently care for patients with Parkinson’s disease (PD) in the inpatient setting. Planning care for those with PD involves a solid understanding of the disease process, symptom management, and medication management. This course explains the pathophysiology, signs and symptoms, drug therapy, and nonpharmacological treatments for PD. Take this course to better understand PD and improve outcomes for your patients with PD.
The goal of this course is to educate nurses, physicians, and pharmacists in the acute care setting on management and treatment of PD.
Healthcare professionals frequently care for patients with Parkinson’s disease (PD) in the inpatient setting. Planning care for those with PD involves a solid understanding of the disease process, symptom management, and medication management. This course explains the pathophysiology, signs and symptoms, drug therapy, and nonpharmacological treatments for PD. Take this course to better understand PD and improve outcomes for your patients with PD. The goal of this course is to educate nurses, physicians, and pharmacists in the acute care setting on management and treatment of PD.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Bahamas Medical Council (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Florida Board of Nursing (CEBroker Provider #50-290)
Florida Physician Assistants (CEBroker Provider #50-290)
Georgia Board of Nursing (CEBroker Provider #50-290)
Georgia Composite Medical Board - Physician Assistants (CEBroker Provider #50-290)
Kansas State Board of Nursing (CEBroker Provider #50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Michigan Board of Nursing (CEBroker Provider #50-290)
Mississippi Board of Nursing (CEBroker Provider #50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
New Hampshire Medical Society (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
New Mexico Board of Nursing (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
North Dakota Board of Nursing (CEBroker Provider #50-290)
State Medical Board of Ohio (CEBroker Provider #: 50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)>
Physicians will receive 1.00 AMA PRA category 1 Credits™
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Wyoming Board of Nursing (CEBroker Provider #50-290)
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: What Is PD?
Background
Pathophysiology
Risk Factors and Causes
Protective Factors
Key Takeaways
Section 3: Signs and Symptoms
Cardinal Signs
Nonmotor
Diagnosis
Staging
Key Takeaways
Section 4: Medications
Complications from Medication
Levodopa (L-dopa)
Dopamine Receptor Agonists
Monoamine Oxidase Type B (MAO-B) Inhibitors
Catechol-O-Methyltransferase (COMT) Inhibitors
Anticholinergics
Medications for Nonmotor Symptoms
Key Takeaways
Section 5: Nonpharmacological Management
Deep Brain Stimulation (DBS)
Nonpharmacologic Treatments
Complementary Therapies
Key Takeaways
Section 6: Clinical Vignette
Meet Russell
Section 7: Conclusion
Course Summary
Course Contributors
Johnny received a B.S. Pharmacy degree from the College of Pharmacy at the Medical University of South Carolina. He has earned certificates in Medication Therapy Management, Injectable Medications, and Asthma Therapy Management. At Relias, Johnny serves as a Partner in Behavioral Health Solutions, where duties include serving on Clinical Analytics and Applications Team, developing algorithms to improve clinical outcomes, engineering clinical consultant, SME, writer, and editor. In addition, he has served on the Executive Board of Directors for CMHCs and other medical organizations, pharmacy manager, APPE Preceptor, and college of pharmacy dean’s advisory council.Writer: Sarah Hunter, RN, SCRN, CNRN, CMSRN
Ms. Hunter is a SME writer at Relias. Her area of expertise is neuroscience nursing, medical-surgical nursing, and thoracic surgery. Ms. Hunter has worked at the bedside for 9 years in acute care and intermediate care at a large community hospital in North Carolina. She also served as chair of the hospital's shared governance council for Nursing Quality Improvement. She has a Bachelor of Arts and an Associate Degree in Nursing. Ms. Hunter is a Stroke Certified RN, Certified Neuroscience RN and a Certified Medical-Surgical RN.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.